fashion -WSS

fashion

author：focus 2025-10-01 23:57:15 - browse：977

Adam's take main illustration — Molly Ferguson/STAT

Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not close. Six months from now, or sooner, Novartis will walk away — slightly embarrassed but otherwise unscathed — happy to pay a small breakup fee to MorphoSys to avoid owning a drug for myelofibrosis that regulators turned away.

MorphoSys will not fare as well from the breakup. Its future, and that of the drug called pelabresib at the center of the deal, will be thrown into limbo.

This is all speculation on my part, but it’s supported by separate conversations with two people familiar with pelabresib and the debate inside Novartis over the MorphoSys acquisition. They requested anonymity to discuss confidential matters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Doctor of U.S. President Joe Biden says he is fit for duty

hotspot

WSS

Russian special forces kill a gunman who broke into a private house near Moscow

Russian special forces kill a gunman who broke into a private house near Moscow

Redefining sustainability for the pharmaceutical industry

'Vaccine

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Marvel Studios reveals new trailer for 'The Marvels': Watch here

leisure time

fashion

focus

The high cost of giving birth even with insurance

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Sports medicine is finally prioritizing gender equality

Virtual repurposing can help discover new uses for existing drugs

Walensky prepares to leave CDC — and Congress — behind

Elisabeth Bik tackles the widespread issue of research misconduct

Medicare details structure of new drug price negotiation program

CDC advisory group OKs chikungunya vaccine

hotspot

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Doctor of U.S. President Joe Biden says he is fit for duty

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Neuroscience renaissance leads to new crop of psychiatric drugs

NEJM study measures Covid brain fog, impact on IQ

explore

hotspot

Wikipedia

entertainment